UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission FileNumber: 001-36867
Allergan plc
(Exact name of registrant as specified in its charter)
Clonshaugh Business and Technology Park
Coolock, Dublin, D17 E400, Ireland
+353 1 435 7700
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Ordinary Shares, par value of $0.0001 per share
Guarantees of Allergan, Inc.’s 3.375% notes due 2020
Guarantees of Allergan Sales, LLC’s 4.875% notes due 2021
Guarantees of Allergan Sales, LLC’s 5.000% notes due 2021
Guarantees of Allergan Finance, LLC’s 3.250% notes due 2022
Guarantees of Allergan, Inc.’s 2.800% notes due 2023
Guarantees of Allergan Finance, LLC’s 4.625% notes due 2042
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule12g-4(a)(1) | ☒ | |||||
Rule12g-4(a)(2) | ☐ | |||||
Rule12h-3(b)(1)(i) | ☒ | |||||
Rule12h-3(b)(1)(ii) | ☐ | |||||
Rule15d-6 | ☐ | |||||
Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date:
Ordinary Shares, par value of $0.0001 per share: One (1) holder
Guarantees of Allergan, Inc.’s 3.375% notes due 2020: Zero (0) holders
Guarantees of Allergan Sales, LLC’s 4.875% notes due 2021: Zero (0) holders
Guarantees of Allergan Sales, LLC’s 5.000% notes due 2021: Zero (0) holders
Guarantees of Allergan Finance, LLC’s 3.250% notes due 2022: Zero (0) holders
Guarantees of Allergan, Inc.’s 2.800% notes due 2023: Zero (0) holders
Guarantees of Allergan Finance, LLC’s 4.625% notes due 2042: Zero (0) holders
Pursuant to the requirements of the Securities Exchange Act of 1934, Allergan plc has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: May 21, 2020 | Allergan plc | |||||
| By: | /s/ Robert A. Michael | |||||
| Name: | Robert A. Michael | |||||
| Title: | Director | |||||
